Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 66.00M | £ 45.80M | £ 99.90M | £ 79.60M | £ 67.50M |
Total Assets | £ 641.60M | £ 588.10M | £ 615.30M | £ 558.60M | £ 549.50M |
Total Debt | £ 32.10M | £ 24.60M | £ 15.90M | £ 14.40M | £ 7.10M |
Net Debt | £ -33.90M | £ -21.20M | £ -84.00M | £ -65.20M | £ -60.40M |
Total Liabilities | £ 151.00M | £ 117.50M | £ 103.60M | £ 74.40M | £ 68.50M |
Stockholders Equity | £ 488.80M | £ 468.40M | £ 509.20M | £ 481.50M | £ 478.10M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |